Muntean Andrew G, Pang Liyan, Poncz Mortimer, Dowdy Steven F, Blobel Gerd A, Crispino John D
Graduate Program in Molecular Genetics and Cell Biology, University of Chicago, IL, USA.
Blood. 2007 Jun 15;109(12):5199-207. doi: 10.1182/blood-2006-11-059378. Epub 2007 Feb 22.
Endomitosis is a unique form of cell cycle used by megakaryocytes, in which the latter stages of mitosis are bypassed so that the cell can increase its DNA content and size. Although several transcription factors, including GATA-1 and RUNX-1, have been implicated in this process, the link between transcription factors and polyploidization remains undefined. Here we show that GATA-1-deficient megakaryocytes, which display reduced size and polyploidization, express nearly 10-fold less cyclin D1 and 10-fold increased levels of p16 compared with their wild-type counterparts. We further demonstrate that cyclin D1 is a direct GATA-1 target in megakaryocytes, but not erythroid cells. Restoration of cyclin D1 expression, when accompanied by ectopic overexpression of its partner Cdk4, resulted in a dramatic increase in megakaryocyte size and DNA content. However, terminal differentiation was not rescued. Of note, polyploidization was only modestly reduced in cyclin D1-deficient mice, likely due to compensation by elevated cyclin D3 expression. Finally, consistent with an additional defect conferred by increased levels of p16, inhibition of cyclin D-Cdk4 complexes with a TAT-p16 fusion peptide significantly blocked polyploidization of wild-type megakaryocytes. Together, these data show that GATA-1 controls growth and polyploidization by regulating cyclin D-Cdk4 kinase activity.
核内有丝分裂是巨核细胞所采用的一种独特的细胞周期形式,在这种形式中,有丝分裂的后期被跳过,从而使细胞能够增加其DNA含量和大小。尽管包括GATA-1和RUNX-1在内的几种转录因子与这一过程有关,但转录因子与多倍体化之间的联系仍不明确。在这里,我们表明,与野生型巨核细胞相比,表现出大小和多倍体化降低的GATA-1缺陷型巨核细胞,其细胞周期蛋白D1的表达量减少了近10倍,而p16的水平增加了10倍。我们进一步证明,细胞周期蛋白D1是巨核细胞而非红细胞中GATA-1的直接靶点。当细胞周期蛋白D1的表达恢复,并伴有其伴侣Cdk4的异位过表达时,巨核细胞的大小和DNA含量会显著增加。然而,终末分化并未得到挽救。值得注意的是,在细胞周期蛋白D1缺陷型小鼠中,多倍体化仅略有降低,这可能是由于细胞周期蛋白D3表达升高的补偿作用。最后,与p16水平升高导致的额外缺陷一致,用TAT-p16融合肽抑制细胞周期蛋白D-Cdk4复合物可显著阻断野生型巨核细胞的多倍体化。总之,这些数据表明,GATA-1通过调节细胞周期蛋白D-Cdk4激酶活性来控制生长和多倍体化。